114 related articles for article (PubMed ID: 36178981)
41. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
42. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
[TBL] [Abstract][Full Text] [Related]
43. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
44. Age-related risk for second breast cancer and gynecological malignant neoplasms after differentiated thyroid cancer.
Zhao X; Yang G; Zhang W; Dong Q; Yang Q
Endocrine; 2022 May; 76(2):385-394. PubMed ID: 35122212
[TBL] [Abstract][Full Text] [Related]
45. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
46. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
47. Age at Primary Malignancy Determines Survival in Adolescent and Young Adults That Develop a Secondary Thyroid Cancer.
Lau BJ; Goldfarb M
J Adolesc Young Adult Oncol; 2016 Jun; 5(2):201-8. PubMed ID: 27042962
[TBL] [Abstract][Full Text] [Related]
48. Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.
Ishida Y; Qiu D; Maeda M; Fujimoto J; Kigasawa H; Kobayashi R; Sato M; Okamura J; Yoshinaga S; Rikiishi T; Shichino H; Kiyotani C; Kudo K; Asami K; Hori H; Kawaguchi H; Inada H; Adachi S; Manabe A; Kuroda T
Int J Clin Oncol; 2016 Jun; 21(3):506-16. PubMed ID: 26620038
[TBL] [Abstract][Full Text] [Related]
49. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
[TBL] [Abstract][Full Text] [Related]
50. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
51. Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia.
Iannacone MR; Youlden DR; Baade PD; Aitken JF; Green AC
Int J Cancer; 2015 Feb; 136(3):603-9. PubMed ID: 24806428
[TBL] [Abstract][Full Text] [Related]
52. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
[TBL] [Abstract][Full Text] [Related]
53. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.
Scélo G; Boffetta P; Corbex M; Chia KS; Hemminki K; Friis S; Pukkala E; Weiderpass E; McBride ML; Tracey E; Brewster DH; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Brennan P
Cancer Causes Control; 2007 Apr; 18(3):269-78. PubMed ID: 17237987
[TBL] [Abstract][Full Text] [Related]
54. Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based study.
Ye Y; Otahal P; Wills KE; Neil AL; Venn AJ
Cancer; 2018 Apr; 124(8):1808-1818. PubMed ID: 29370456
[TBL] [Abstract][Full Text] [Related]
55. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis.
Jiang S; Jiang H; Sun L; Luo Z
Curr Probl Cancer; 2021 Apr; 45(2):100641. PubMed ID: 32928566
[TBL] [Abstract][Full Text] [Related]
56. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Neglia JP; Robison LL; Stovall M; Liu Y; Packer RJ; Hammond S; Yasui Y; Kasper CE; Mertens AC; Donaldson SS; Meadows AT; Inskip PD
J Natl Cancer Inst; 2006 Nov; 98(21):1528-37. PubMed ID: 17077355
[TBL] [Abstract][Full Text] [Related]
57. Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.
Caini S; Radice D; Tosti G; Spadola G; Cocorocchio E; Ferrucci PF; Testori A; Pennacchioli E; Fargnoli MC; Palli D; Bazolli B; Botteri E; Gandini S
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1491-6. PubMed ID: 26990937
[TBL] [Abstract][Full Text] [Related]
58. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
59. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
Lal G; Groff M; Howe JR; Weigel RJ; Sugg SL; Lynch CF
Ann Surg Oncol; 2012 Jun; 19(6):1887-96. PubMed ID: 22227921
[TBL] [Abstract][Full Text] [Related]
60. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]